FDA Panel to Decide Fate of Egrifta, a Promising Gut Fat Fighter
A U.S. Food and Drug Administration (FDA) advisory panel is convening this week to decide whether to recommend approval of Egrifta, a belly fat-busting drug for HIV-positive people with lipodystrophy. The drug’s fate is far from certain, but activists are hopeful.
David Munar: Growing at the AIDS Foundation of Chicago
The AIDS Foundation of Chicago’s vice president, David Munar, discusses his career as an advocate,
the challenges facing the Latino HIV/AIDS community and his efforts working with
the White House to develop a national AIDS strategy.
May 12, 2010
Preparing for the Aging HIV Epidemic
A new report from GMHC details the steps necessary to prepare our health care system for the increasing 50-and-older HIV-positive population. (Watch video.)
May 05, 2010
Erica Douglas: Empowering Black Women in the Florida Panhandle
Erica Douglas, the regional minority AIDS coordinator for the Escambia County Health Department in Pensacola, Florida, is working with Sistas Organizing to Survive (SOS) to put together the region’s first Women’s Health and Empowerment Conference, which will be held May 15. POZ spoke with Douglas about this conference and the challenges of reaching African-American women in Florida.
START Wars HIV experts are at odds regarding an uptick in public policy and advocacy efforts to promote early HIV treatment, in light of the unknowns surrounding its potential benefits and risks. A clinical trial—the 4,000-patient START study—is now under way to explore some of the most pressing questions. But should activists and advocacy groups be waiting for answers?